Febuxostat 80 mg/day vs placebo
Serious adverse events · people with chronic gout
Febuxostat 80 mg/day showed no clear difference in serious Adverse Events compared with placebo (moderate certainty).
1 finding from 1 review
- RR 2.8 [0.72, 10.7]2 studies · 479 participantsModerate